Medindia
Medindia LOGIN REGISTER
Advertisement

Evogen Receives U.S. Patent Covering Its Novel Epilepsy Blood Test

Wednesday, September 27, 2017 General News
Advertisement
--Patent Covers Key Biomarkers in Evogen's EvoScoreDX™ Biomarker-Based Blood Test for Distinguishing Epileptic Seizures; Addresses Major Unmet Need for Better Epilepsy Diagnostics--

Contacts

Evogen Corporate:

Evogen Media:

Richard St. Clair

Barbara Lindheim

[email protected]

[email protected]

212 584-2276

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close